Scientists probe MS Drug's hidden effects on immune system
NCT ID NCT06415864
Summary
This study aimed to understand how the approved MS drug, oral cladribine, changes specific immune cells in the body and spinal fluid over two years. It involved 10 people with relapsing-remitting MS who were already taking the drug. Researchers measured detailed changes in B-cells and T-cells to learn more about how the treatment works.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Barts Health NHS Trust
London, United Kingdom
Conditions
Explore the condition pages connected to this study.